Wednesday, 26 May 2021

Magnetic Resonance Imaging Market Get Facts About Business Strategies 2021 to 2028: Grand View Research Inc.

 

Magnetic Resonance Imaging or MRI or sometimes called nuclear magnetic resonance is specifically suitable to provide images of the internal organs. Unlike other imaging methods, such as CT scan or X-Ray, the risk of harmful radiation is omitted in the case of magnetic resonance imaging.

Before discussing most imperative questions regarding magnetic resonance imaging (MRI), we should firstly understand the meaning of MRI, how it works, and its uses.

Let’s dive in.

Request a free sample copy or view report summary: MRI Market Report

What is Magnetic Resonance Imaging (MRI)?

Magnetic Resonance Imaging (MRI) is an imaging method that uses magnetic waves to obtain detailed images of organs inside a body. The primary objective of MRI is to detect potential or present diseases in a body such as tumors, risks involving stroke, heart diseases, evaluation of kidney, pelvic organs, and many others.

The MRI scanner is an efficient diagnostic machine in a shape of a tube surrounded by a giant circular magnet. During the process of scanning, the patient is made to lie inside the machine. A heavy magnetic field is generated by the magnet, which aligns the protons of hydrogen atoms, which are then subjected to a beam of radio waves. The numerous protons in the body move, producing a faint signal that is sensed by the MRI scanner’s receiver component. The receiver information is processed by a computer, which results in a photograph.

What are the Uses of MRI scan?

When other tests fail to provide enough evidence to validate a patient’s diagnosis, an MRI scan may be used as an incredibly reliable means of disease identification in the body. It is often used after other research fails to provide enough information to confirm a patient’s diagnosis.

For instance, a magnetic resonance imaging scan is used by neurosurgeons not only to determine brain structure but also to assess the spinal cord’s stability following trauma. It’s often used for dealing with issues involving the spine’s vertebrae or intervertebral discs.

Why does an MRI machine make loud noise while scanning?

As we all know now, a powerful magnetic field is used in an MRI scan. During the scan, a superconducting magnet creates a solid base magnetic field. A series of electromagnets coiled in 3-axis within the magnet undergoes a slight, predictable change in field strength in each direction. The wires within the epoxy casing travel and create noise as the electromagnets are turned on and off.

Major differences between CT scan, X-Ray, and MRI?

Difference between x-ray ct scan mri

CT scan, MRI, or X-Ray are not new terminologies in the healthcare sector. Doctors have been using these machines for ages to detect what is going inside our body. These images can help in screening for possible medical conditions before symptoms appear along with diagnosing the cause of existing symptoms or monitor health conditions that have been diagnosed and the effects of treatment for them. To just name of few, different types of imaging include CT scan, X-rays, MRI, and Ultrasound. Each of these imaging types uses different technology to create an image of our body. Let’s discuss a few of these imaging types and understand the major differences between them.

xray ct scan mri
X-Rays vs Ct Scan vs MRI (Infographic)

Discussing if there are any health risks related to MRI scan, or it’s all myth.

MRI scan is fairly a risk-free scan but there are some minor risks involved during the procedure. However, there is no major health risk related to MRI as it doesn’t involve the use of radiation.

Since an MRI scan is performed inside a very powerful magnetic field, it is necessary to remove all metallic objects before the scan, including hearing aids, watches, jewelry, mobile phones, and cloths with metallic threads or fasteners. Additionally, it is advisable to remove all lipstick, nail polish, or other products that may contain metallic particles.

A contrast agent known as gadolinium is inserted into a vein during specific MRI exams to help enhance the detail seen on the magnetic resonance images. Gadolinium does not contain iodine, unlike contrast products used in x-ray exams or CT scans, and therefore rarely induces an allergic reaction or other problem.

Claustrophobia is another risk associated with an MRI scan. Though an individual can opt for an Open MRI, the possibility of which can be discussed with the doctor.

Future of Magnetic Resonance Imaging (MRI)

MRI has been at the pinnacle of medical imaging, having a huge impact on many developments in diagnostic radiology. Most of the developing countries have benefitted from advancements in MRI hardware and applications.

So, where is MRI technology heading?

Well, the biggest manufacturers and researchers across the world are trying to take MRI technology towards portability. The current MRI machines are hefty and bulky which needs an entire room for it. In several cases, a portable MRI can be beneficial for the assessment of treatment. One such portable MRI launched by Hyperfine was launched in 2020 to scan the head, neck and, other extremities in about any clinical setting. The portable MRI can be used in emergency rooms, intensive care units, and places where a clinical MRI can’t be accessed.

Pharmaceutical Analytical Testing Outsourcing Market Expected to Witness a Sustainable Growth over 2028

  

Do you remember when we go to the office, what is the expectation of our boss from us?

Quality work submitted on time. Maybe?

When we look back to our school and college time, isn’t the same thing that our teacher used to expect from our assignments?

Even today, is quality, not our topmost priority when we do some work or when somebody is doing something for us?

Henceforth, QUALITY IS IMPORTANT.

Just like for us, quality work is also important in the pharmaceutical industry whether it’s method validation, tech transfer, microbiological testing, or method development. In this regard, here what people working in this industry has to say:

Quality results are what pharma wants; rarely do we hear complaints about cost.

Michael Crowley, Ph.D., M.S., B.S., Vice President business development, PharmaForm

The key to everything in our industry is quality. Not only does this refer to the quality of the data, but also the quality and reliability in delivery; the quality of the relationship as well as trust; quality associated with regulatory adherence; quality associated with the communication; quality of the science and people; and quality in working through problems and issues.”

Randall Guthrie, Vice President, Xcelience, LLC

Price rarely comes up in conversation with clients.

Request a free sample copy or view report summary: Pharmaceutical Analytical Testing Outsourcing Market Report

Frank Santillo, Ph.D., senior director of research services for Bilcare Global Clinical Services

Increasing R&D budgets and investments in drug discovery are among the critical sustainability strategies for pharmaceutical companies. Not all companies have an infrastructure that is conducive to all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost.

Other factors, such as the increasing need for product safety & quality, along with changing regulations for in vivo and in vitro tests are also expected to propel the growth of the market. For instance, the government of China issued a notification to upgrade the quality of generic drugs, remove the backlog of drug applications, improve the quality and transparency of the review and approval process, and encourage new drug R&D in line with global development.

Some key points to note:

  • As per the latest report by Grand View Research, the global pharmaceutical analytical testing outsourcing market size was valued at USD 6.54 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.3% over the forecast period.
  • Innovation in the pharmaceutical industry, increasing focus on regulation, safety & quality, rising number of end-users, and pricing benefits of outsourcing are the key factors driving the market.
  • In several nations, analytical laboratories are considered to be a part of the essential healthcare infrastructure, thus analytical studies were continued with minimal or no initial disruptions due to COVID-19.
  • The Asia Pacific is expected to be the fastest-growing regional market from 2021 to 2028 as a lot of developed countries are investing in countries in this region.
  • Some prominent players in the global pharmaceutical analytical testing outsourcing market include:
    • SGS SA
    • Toxikon, Inc.
    • Eurofins Scientific
    • Pace Analytical Services, Inc.
    • Intertek Group Plc
    • Pharmaceutical Product Development, LLC.
    • WuXi AppTec, Inc.
    • Boston Analytical
    • Charles River Laboratories International, Inc.
    • West Pharmaceutical Services Inc.

Access Our Blog@ https://gvrencompass.wordpress.com

Medical Device Outsourcing Market Poised for Robust Value CAGR of Over 11.2% Through 2028

 Today’s Covid-19 pandemic world shows a macrocosm of the challenges for companies in the life sciences field. The global Covid-19 death toll surpassed three million and new cases continue to spike as we head into the second quarter of the year. However, the medical device companies are still striving to adapt to the rapidly changing needs of the healthcare system and the supply chain ecosystem– whether it’s dealing with the decline in sales of elective surgery equipment or struggling to keep up with the mounting demand for ventilators, personal protective equipment, testing equipment, and oxygen cylinders, which has been overwhelming. Therefore, most of the companies have made a shift toward outsourcing R&D services to reduce costs, hasten product market entry, and minimize business risks, and thus fuel the overall market growth.

Request a free sample copy or view report summary: Medical Device Outsourcing Market Report

On top of that, the medtech industry is working out the optimal ways to respond to the enormous disruptions caused by Covid-19 outbreak that hampered daily working life. Device development, recruitment, sales, quality management, and medical investigations aren’t an optional measure for most device manufacturing companies. Since they want to stay afloat during this extraordinary period of disruption, they have distributed these functions under the yoke of social distancing norms, while wholly justified, making it difficult than ever to collaborate effectually.

As the supply chains adapt to a reformed distanced world, let’s check out the benefits of outsourcing your medical checklist.

Capitalize on resources: Medical device outsourcing empowers OEMs to take advantage of the available third-party resources. It eliminates the need to store or source them locally and is more cost-effective. Countries including China, Korea, and Taiwan are top medical device manufacturers. It is therefore more viable for US-based companies to outsource manufacturing operations overseas.  

Focus on core activities: given the time saved because of outsourcing, companies can better utilize their time and local resources on improving other core activities such as marketing, R&D of new devices, and promotion of existing products.

Data and information security: One of the key pressing challenges in medical device manufacturing activities is the threat of private information breach. In the outsourcing process, companies are becoming more aware and informed to avoid such breaches with the help of security contracts.

Reimbursement policies: The incessant pressure on companies to reduce the product costs is hampering the medical device market. Though there is a protuberant surge in healthcare expenditure, many medical providers are still unwilling to reimburse medical devices. However, reformed reimbursement policies are likely to ace the outsourcing infrastructure in the coming years

Medical Device Outsourcing Market Highlights

  • The contract manufacturing was the leading segment in 2020 with a revenue share of 55.4% and is anticipated to retain its position throughout the forecast period
  • The market is driven by the increasing outsourcing activities by OEMs to third-party manufacturers, particularly in emerging countries
  • Asia Pacific was the dominant regional market in 2020 and can be attributed to the easy availability of skilled human resources

List of Key Players of Medical Device Outsourcing Market

  • SGS SA
  • IQVIA
  • Toxikon, Inc.
  • Eurofins Scientific SE
  • Pace Analytical Services, Inc.
  • Intertek Group plc
  • WuXi AppTec, Inc.
  • North American Science Associates, Inc.
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corp.

Access Our Blog@ https://gvrencompass.wordpress.com

Industries need to adopt permanent, long-term solutions to challenges that arose due to the COVID-19 pandemic. Groundbreaking innovations resolving supply chain resiliency, coupled with product supply chain lifecycle management are the vital pillars to pivot adequacy in the face of an unexpected event in the future. Global supply chains are here to stay and investing in building a strong supply base and risk management systems such as predictive supply chain management is considered the best road to tread in the post-COVID world.

Tuesday, 25 May 2021

Outdoor Solar LED Market Estimated To Flourish By 2028: Grand View Research Inc.

 Outdoor Solar LED Market Growth & Trends

The global outdoor solar LED market size is expected to reach USD 24.75 billion by 2028, registering a CAGR of 24.6% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. The use of solar PV cells in urban spaces for outdoor lighting applications has substantially increased over the last couple of years. The increased demand for these products can be attributed to their benefits on the fronts of energy efficiency, maintenance cost, and power cost over traditional lighting. As of 2020, the Europe market, closely following the Asia Pacific market in terms of market size, has witnessed a slight uptick in market demand with favorable regulations and incentive schemes supporting large-scale adoption.

Such government rebates and initiatives aimed at creating awareness about green, energy-saving products are anticipated to drive the adoption of solar LED products in commercial applications. For instance, Pacific Gas and Electric Company (PG&E), a U.S.-based combined electric energy company, provides zero percent interest loans to non-residential customers for energy-saving projects, including implementing solar LED lighting systems. Similarly, the U.K. government implemented the Enhanced Capital Allowance (ECA) initiative to promote the adoption of energy-efficient lighting solutions among businesses in exchange for tax benefits.

Solar LEDs are also making their way in the DIY/decorative lights category. Several residential owners are spending on solar LEDs as a part of small-scale residential landscape projects and events. Furthermore, to promote the adoption of renewable and energy-efficient products such as solar lightings and LEDs, several utilities, and local governing bodies are offering rebates and discount schemes for residential owners. Thus, the increasing awareness about energy conservation and collaborative efforts taken by governments are likely to drive the adoption of solar LEDs in the residential sector.

Request a free sample copy or view report summary: Outdoor Solar LED Market Report

Outdoor Solar LED Market Report Highlights

  • In terms of application, the solar garden LED lights segment is expected to register the highest CAGR over the forecast period. The increasing spending on garden landscape designing in the residential and commercial spaces, to make the gardens aesthetically pleasing, is expected to drive the adoption of solar garden LEDs over the forecast period
  • In terms of wattage, the 40W to 149W segment captured the largest revenue share in 2020. These products are gaining popularity due to their attributes such as higher lumen and brightness, which make them particularly suitable for landscaping and street lighting applications
  • The demand for outdoor solar LEDs in commercial spaces is estimated to record a CAGR of around 25% from 2021 to 2028. The often large scale of commercial projects calls for a large number of lighting products, which is expected to favor the segment growth
  • With an increase in infrastructure development projects in China, India, and Japan, the Asia Pacific market held a substantial market share exceeding 40.0% in 2020 Growing investments in renewable and energy-saving programs across several countries in the region are anticipated to favor the growth of the regional market over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-outdoor-solar-led-market

Outdoor Solar LED Market Segmentation

Grand View Research has segmented the global outdoor solar LED market based on application, wattage, end-use, and region:

Outdoor Solar LED Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Solar LED Street Lights
  • Solar Garden LED Lights
  • Solar LED Floodlights
  • Solar LED Area Lights
  • Solar LED Spot Lights

Outdoor Solar LED Wattage Outlook (Revenue, USD Million, 2016 - 2028)

  • Less than 39W
  • 40W to 149W
  • More than 150W

Outdoor Solar LED End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Residential
  • Commercial
  • Industrial

Outdoor Solar LED Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Southeast Asia
    • South Asia
  • Latin America
    • Brazil
    • Mexico
  • MEA

List of Key Players of the Outdoor Solar LED Market

  • Solar Street Lights USA
  • OkSolar
  • SOLTECH
  • Jiangsu Beier Lighting Electrical Appliance Co., Ltd.
  • SEPCO Solar Electric Power Company
  • Jiawei

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sparkling Coffee Market Latest Trends, Industry Growth And Forecast To 2028: Grand View Research Inc.

 Sparkling Coffee Market Growth & Trends

The global sparkling coffee market size is expected to reach USD 1.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.0% from 2021 to 2028. The high consumption of coffee across Europe and North America has been driving the market. Furthermore, increasing preference for convenient ready-to-drink (RTD) beverages has been boosting the sales of RTD coffee over the world.

With the rise in demand for healthier alternatives to soda and carbonated options, without compromising on the taste and texture of carbonation, sparkling coffee witnesses an increased demand globally. Consumers are looking for good alternatives that can help reduce their intake of added sugar while also receive some additional health benefits. This trend is foreseen to remain prevalent over the forecast period and provide the market with numerous growth opportunities.

The caffeinated product segment dominated the market with more than 80.0% share in 2020. The growing demand for healthy energy drinks due to the rising concerns over personal health and wellness is anticipated to boost the growth of this segment. Caffeine in drinks helps in increasing alertness and concentration throughout the day. Moreover, the introduction of new flavors along with caffeine is expected to drive the demand for these products.

Major players in the market for sparkling coffee have significant reach in hypermarket and supermarket, grocery, convenience, and other local stores as customers are developing interest to try new coffee trends in such convenient places. Local liquor stores also sell the drink in some countries. For Instance, in the U.S., sparkling coffee offered by DrinkVIVIC is available in Big Mac's Liquor, Lawlers Liquors, and M&B Liquors. The growing niche market of sparkling coffee has been attracting new players, and hence competition has been intensifying over the last few years.

Request a free sample copy or view report summary: Sparkling Coffee Market Report

Sparkling Coffee Market Report Highlights

  • By product, the decaffeinated segment is expected to register the fastest growth rate of 13.4% from 2021 to 2028
  • The online distribution channel segment is expected to register the fastest CAGR of 13.7% from 2021 to 2028 owing to the increasing adoption of e-commerce among the young consumers
  • North America held the largest share of more than 45.0% in 2020 owing to the presence of several companies in the region
  • The caffeinated product segment held the largest share of more than 80.0% in 2020

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sparkling-coffee-market

Sparkling Coffee Market Segmentation

Grand View Research has segmented the global sparkling coffee market on the basis of product, distribution channel, and region:

Sparkling Coffee Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Caffeinated
  • Decaffeinated

Sparkling Coffee Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Hypermarket & Supermarket
  • Convenience Stores
  • Online
  • Others

Sparkling Coffee Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
  • Europe
    • Germany
    • UK.
    • Italy
    • Spain
    • France
  • Rest of the World

List of Key Players of Sparkling Coffee Market

  • DrinkVIVIC
  • MATCHLESS COFFEE SODA
  • Keepers Sparkling Coffee
  • Upruit
  • Union Coffee
  • Paulig
  • Slingshot Coffee Co.
  • Nongfu Spring
  • Stumptown Coffee Roasters
  • Manhattan Special

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Terminal Sterilization Services Market Is Projected To Reach Approximately USD 19.5 Billion By 2028: Grand View Research Inc.

 Terminal Sterilization Services Market Growth & Trends

The global terminal sterilization services market size is anticipated to reach USD 19.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.3% from 2021 to 2028. The current advent of the novel COVID-19 pandemic has led to the growing demand for sterilization services and is expected to reach new frontiers in the upcoming months. As more and more people are getting infected with COVID, it is likely to create a demand for critical care equipment, which is leading to the growth of the market, globally. This is anticipated to provide plenty of opportunities for market players.

The mounting concerns over healthcare-associated infections spread through the environment or person are the major factor augmenting the market. As per CDC, in the U.S., it was estimated that HAIs account for approximately 1.7 million infections and 99,000 associated deaths each year, thus driving the market.

Growth in the pharmaceutical and biotechnology sector has had a tremendous impact on market growth. According to the Pharmaceutical Research and Manufacturers Association estimates 2018, the U.S.-based biopharmaceutical companies invested nearly USD 102.0 billion in R&D. Thus, increased R&D activities result in increased demand for various sterilization processes in these industries, thereby, fueling market growth during the forecast period.

Furthermore, the introduction of innovative products and the incorporation of new technologies by market players are expected to contribute to market growth during the forecast period. For instance, in April 2020, Matachana Group launched new steam sterilizers-MPHS Series-specifically designed to meet the guidelines of the pharmaceutical industry.

Request a free sample copy or view report summary: Terminal Sterilization Services Market Report

Terminal Sterilization Services Market Report Highlights

  • On the basis of product, the ethylene oxide segment dominated the market and accounted for a revenue share of 34.9% in 2020 owing to numerous advantages offered by this method such as simple penetration, large sterilizing volume, and broad material compatibility
  • Based on end-use, the pharma segment dominated the market and accounted for a revenue share of 67.0% in 2020. Increasing R&D activities and the launch of complex equipment are boosting demand for the sterilization process in pharmaceutical companies
  • North America dominated the market and accounted for a revenue share of 35.6% in 2020 owing to increased adoption of standard sterilization services among hospitals and research centers. Additionally, the constantly expanding patient pool is further driving the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-terminal-sterilization-service-market

Terminal Sterilization Services Market Segmentation

Grand View Research has segmented the global terminal sterilization services market on the basis of product, end-use, and region:

Terminal Sterilization Service Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Ethylene Oxide
  • Irradiation
  • Moist Heat Terminal Sterilization
  • Others

Terminal Sterilization Service End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals & Clinics
  • Pharma
  • Others

Terminal Sterilization Service Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Terminal Sterilization Services Market

  • Steris Plc
  • Getinge Group
  • Advanced Sterilization Products Services, Inc.
  • 3M
  • Belimed
  • Cantel Medical
  • Matachana Group
  • Sterigenics International LLC
  • Olympus Corp.
  • TSO3

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Glassware Market Predicted to Witness Steady Growth During the Forecast Period

 Europe Glassware Market Growth & Trends

The Europe glassware market size is expected to reach USD 4.01 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The market is expected to witness prominent growth in the future owing to the economic growth in emerging countries and the development of attractive glassware products.                              

Furthermore, the increasing urbanization is one of the prominent factors leading to a change in the purchasing behavior of consumers. The growing population due to the migration of individuals from different countries has increased the number of glassware purchases as per the individual’s preference, in turn, propelling the product demand. A majority of the population in each EU-27 Member State lived in owner-occupied dwellings in 2018, this share ranging from 51.4% in Germany to 96.4% in Romania; the EU-27 average was 70.0%. The trend of living in rental houses has resulted in individuals often changing their houses, thus triggering the product demand as individuals prefer new glassware in their new house.

A rise in alcohol consumption is also acting as a major driver for the market from both the residential and commercial sectors. According to a 2019 report by the WHO, on average, adults (aged 15 years and over) in the European Union countries drink the equivalent of more than 2 bottles of wine per week. When lifetime abstainers and former drinkers are removed, it reveals that adults drink more than 3 bottles of wine a week. Across the population, 30.4% of people report having consumed more than 60g of pure alcohol on a single occasion in the last 30 days - this is equivalent to more than 5 drinks on 1 occasion.

The growing trend of nuclear families is creating more opportunities and growth prospects for the market. In addition, the frequency of formal dining occasions at home is increasing, thereby creating more demand for luxury and premium glassware among consumers. However, the use of plastic ware in various small restaurants due to their low cost and less maintenance is projected to restrain the market growth in the commercial sector. However, increasing awareness about the health benefits of using glassware for drinking can negate the effect of the restraining factors.

The growth of the commercial sector, particularly restaurants and cafes, in the region is creating a high demand for glassware. As per the Specialty Coffee Association (SCA), in 2017, there were 301,593 cafes and 13,344 coffee-focused shops in Western Europe. The uptick in the number of café outlets is increasing the need for glassware products, which is likely to boost the growth prospects for the market over the forecast period. In Europe, the U.K. is foreseen to remain at the forefront and is projected to expand at a notable CAGR over the forecast period.

Request a free sample copy or view report summary: Europe Glassware Market Report

Europe Glassware Market Report Highlights

  • By product, the wine glass segment is projected to be the fastest-growing segment over the forecast period
  • Based on distribution channel, the specialty stores segment dominated the market with a share of over 37.0% in 2020
  • In terms of branding, the branded glassware segment is expected to expand at the fastest CAGR of 9.2% from 2021 to 2028
  • In Europe, the U.K. held the largest share of almost 16.0% in 2020 and is foreseen to remain at the forefront in the forthcoming years

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-glassware-market-analysis

Europe Glassware Market Segmentation

Grand View Research has segmented the Europe glassware market on the basis of product, distribution channel, branding, and country:

Europe Glassware Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Beer Glass
  • Wine Glass
  • Cocktail Glass
  • Spirits Glass
  • Others

Europe Glassware Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Supermarkets & Hypermarkets
  • Specialty Stores
  • Online Retail
  • Others

Europe Glassware Branding Outlook (Revenue, USD Million, 2016 - 2028)

  • Branded Glassware
  • Non-branded Glassware                      

Europe Glassware Country Outlook (Revenue, USD Million, 2016 - 2028)

  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Benelux
    • Russia

List of Key Players of Europe Glassware Market

  • ÅžiÅŸecam Glassware
  • Villeroy & Boch AG
  • Fiskars Group
  • Lifetime Brands, Inc.
  • Ritzenhoff AG
  • Steelite International
  • Alessi S.p.A.
  • Arc International
  • Oertel & Co. Kristallglas
  • Bormioli Rocco S.p.A. 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Large Molecule Bioanalytical Technologies Market During 2021 – 2028 to Gain Robust Traction

 Large Molecule Bioanalytical Technologies Market Growth & Trends

The global large molecule bioanalytical technologies market size is expected to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 13.5% from 2021 to 2028. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

Request a free sample copy or view report summary: Large Molecule Bioanalytical Technologies Market Report

Large Molecule Bioanalytical Technologies Market Report Highlights

  • The product segment accounted for the largest revenue share in 2020
  • Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing
  • Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth
  • Mass spectrometry captured the maximum revenue share in 2020 due to the diversification of products as well as their frequent usage
  • This technology has been conventionally used in the development of protein pharmaceuticals, for instance, in the analysis of confirmations of amino acids in proteins
  • Furthermore, quantitative PCR (qPCR) is widely adopted in the detection of viral contaminants during the manufacture of biopharmaceuticals
  • Thus, with the growing demand for viral vectors, this technology is anticipated to witness the fastest growth over the forecast period
  • Moreover, the presence of a wide array of products in spectrometry is one of the key industry factors driving investment in the segment
  • Biologics accounted for the major revenue share in 2020 owing to the ever-expanding R&D activity programs in the segment
  • Besides, the presence of a stringent regulatory framework for advanced therapies has increased the demand for bioanalytical testing services
  • The COVID-19 pandemic has accelerated the development of genetic vaccines
  • This increases the utility of analytical tools for assessing the safety and stability of large molecules, thereby driving the segment
  • North America dominated the market in 2020 owing to the presence of strong research as well as a commercial base for biopharmaceutical manufacturing
  • Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption and usage of large molecule bioanalytical technologies in the region
  • In the Asia Pacific, the market is estimated to register the fastest CAGR with emerging markets such as China and Japan at the forefront
  • Collaborations between domestic and global players for expansion of biomanufacturing capabilities are supplementing the growth of the market in the region
  • Key companies are focusing on new product launches to sustain their position in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-large-molecule-bioanalytical-technologies-market

Large Molecule Bioanalytical Technologies Market Segmentation

Grand View Research has segmented the global large molecule bioanalytical technologies market on the basis of product & service, technology, application, and region:

Large Molecule Bioanalytical Technologies Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

  • Product
    • Consumables & Accessories
    • Instruments
    • Reagents & Kits
  • Service

Large Molecule Bioanalytical Technologies Outlook (Revenue, USD Million, 2017 - 2028)

  • Electrophoresis
  • Chromatography
  • Mass Spectrometry
  • Western Blot
  • ddPCR, qPCR, RT-PCR
  • ELISA
  • Flow Cytometry
  • Spectrometer
    • UV/VIS
    • CD
    • Raman
    • Laser-induced breakdown spectroscopy
    • Other Spectroscopy techniques
  • Analytical Ultracentrifugation
  • Light scattering (MALS, DLS) & static light scattering
  • DNA Sequencing
  • Other Technologies

Large Molecule Bioanalytical Technologies Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Biologics
    • By Type
      • Monoclonal Antibodies (mAbs)
      • Vaccines
      • Recombinant proteins
    • By Technology
      • Spectrometer
      • Western blot
      • Isoelectric focusing
      • Capillary electrophoresis (CE)
      • Peptide mapping and sequencing by LC-MS/MS
      • Peptide fingerprinting by Chromatography and Mass Spectrometry (MS)
      • ddPCR, qPCR, RT-PCR
      • Others
    • Cell & Nucleic Acid Therapy
      • SDS-PAGE or capillary gel electrophoresis
      • Chromatography
      • Mass Spectrometry/LC-MS
      • UV-Vis Spectrometry
      • ddPCR, qPCR, RT-PCR
      • ELISA Assays
      • Fluorescent Assays
      • Luminescent Assays
      • Western blot
      • Flow Cytometry
      • Others
    • Viral Vector
      • Sanger
      • qPCR, ddPCR, & RTPCR
      • ELISA
      • Electrophoresis
      • NGS
      • Mass Spectrometry
      • Chromatography
      • Dynamic & Static Light Scattering
      • Others
    • Gene Therapy
      • SDS-PAGE or capillary gel electrophoresis
      • Chromatography
      • Mass Spectrometry /LC-MS
      • UV-Vis Spectrometry
      • ddPCR, qPCR, RT-PCR
      • ELISA Assays
      • Fluorescent Assays
      • Luminescent Assays
      • Western blot
      • Flow Cytometry
      • Others
    • Nanoparticles & Polymers
      • Dynamic & static light scattering
      • Laser Diffraction
      • Fluorescence spectrometry
      • Others

Large Molecule Bioanalytical Technologies Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

List of Key Players in Large Molecule Bioanalytical Technologies Market

  • Intertek Group plc.
  • Solvias AG
  • Bio-Techne Corporation
  • Wyatt Technology Corporation
  • Precision NanoSystems
  • Verder
  • Halo Labs
  • Charles River Laboratories International, Inc.
  • Avomeen
  • Merck KGaA
  • Cergentis B.V.
  • Laboratory Corporation of America Holdings
  • SCIEX
  • Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Mesenchymal Stem Cells Market to Surpass USD 6.1 Billion by 2028: Grand View Research Inc.

 Mesenchymal Stem Cells Market Growth & Trends 

The global mesenchymal stem cells market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.6% from 2021 to 2028. Mesenchymal stem cells (MSCs) are set to gain popularity among healthcare professionals, to develop novel therapeutics, primarily targeted at the treatment of several immune-mediated disorders. MSCs have been acclaimed effective as a regenerative therapy for skeletal tissue repair and have recently gained traction across modulation of immune cells and endogenous tissues.

Expanding clinical applications of mesenchymal stem cells, strengthening the pipeline of these therapies, along with intensifying market competition are some of the key aspects driving the industry expansion of MSCs. The recent pandemic outbreak of COVID-19 is set to propel the clinical applications and investments done in this market space. For instance, in April 2020, Canada’s The Stem Cell Network (SCN) provided funding of USD 300,000 to the project targeted towards the evaluation of optimal dosage of MSCs, to design an effective therapeutic approach to reduce the impacts of respiratory disorders associated with SARS-CoV-2 infection.

Additionally, as stated by clinicaltrials.gov, 21 clinical trials reportedly incorporated MSCs in the management of COVID-19. Apart from the applications of MSCs in regenerative medicine and tissue engineering, the MSCs serve as a potent therapeutic approach for cancer treatment. As of February 2020, 25 clinical trials have been registered that employ MSCs in the treatment of several cancer indications. This is set to drive the mesenchymal stem cells market (MSCs) market.

Acknowledging the profitable opportunities posed by the market, key industry participants are focused towards initiating technological collaborations to strengthen their market presence. In August 2020, NantKwest Inc. collaborated with Generate Life Sciences Co. to develop a mesenchymal stem cell-based treatment against COVID-19. The latter company is providing with the MSCs derived from donated umbilical cord tissues.

Request a free sample copy or view report summary: Mesenchymal Stem Cells Market Report

Mesenchymal Stem Cells Market Report Highlights

  • Widespread use of bone marrow derived MSCs in several therapeutic applications has resulted in the segment’s dominance in 2020
  • More than 20.0% of clinical trials incorporate bone marrow MSCs, which is set to maintain the segment’s largest revenue share up to 2028
  • The cancer indication segment is expected to witness rapid growth through 2021 to 2028, attributed to the emergence of MSCs as a promising vehicle for anti-cancer drugs
  • This is attributed to the tumor tropism ability of MSCs and their ability to manage the predestination of tumor cells
  • Disease modelling application generated the highest revenue in 2020, owing to several advantages associated with MSCs such as the high capacity of expansion and self-renewal and reduced tumorigenic capacity, which makes them suitable across disease modelling applications
  • The kits, media, and reagents segment held a significant revenue share in 2020 owing to the presence of a substantial number of service providers and increasing demand in the market
  • The allogeneic segment dominated the market in 2020; Implantation of allogeneic mesenchymal stem cells serves as a promising tool for cell-based therapy
  • As of August 2019, more than 200 clinical trials have been reported for use of allogeneic MSCs, which is expected to propel the segment’s revenue generation capacity from 2021 to 2028
  • Apart from the availability of advanced research facilities and skilled professionals, favorable government initiatives and high R&D expenditure, active policies pertaining to cell therapies have contributed to the dominance of North America MSCs market in 2020
  • For instance, in August 2020, the Centers for Medicare and Medicaid Services proposed new policies that include cellular therapies, wherein, commercial insurance companies support private health plans associated with MSCs
  • The key players are engaged in exploring MSC therapy to its highest potential across different emerging applications, contributing to market growth
  • For instance, in July 2020, Promedica presented positive results from its study that evaluated the use of allogeneic MSCs in COVID-19 patients. The study was conducted under the U.S. FDA’s Emergency Investigational New Drug (IND) approval

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mesenchymal-stem-cells-market

Mesenchymal Stem Cells Market Segmentation

Grand View Research has segmented the global mesenchymal stem cells market on the basis of products and services, type, source of isolation, indication, application, and region:

Mesenchymal Stem Cells Products & Services Outlook (Revenue, USD Million, 2017 - 2028)

  • Products
    • Workflow Type
      • Cell Sourcing & Isolation
      • Culture & Cryopreservation
      • Differentiation
      • Characterization
    • Product Type
      • Cells & Cell Lines
      • Kits, Media, & Reagents
      • Others
    • Services

Mesenchymal Stem Cells Type Outlook (Revenue, USD Million, 2017 - 2028)

  • Autologous
  • Allogeneic

Mesenchymal Stem Cells Source of Isolation Outlook (Revenue, USD Million, 2017 - 2028)

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

Mesenchymal Stem Cells Indication Outlook (Revenue, USD Million, 2017 - 2028)

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

Mesenchymal Stem Cells Application Outlook (Revenue, USD Million, 2017 - 2028)

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cells Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

List of Key Players of Mesenchymal Stem Cells (MSCs) Market

  • Thermo Fisher Scientific, Inc.
  • Cell Applications, Inc.
  • Cyagen Biosciences Inc.
  • Axol Biosciences Ltd.
  • Cytori Therapeutics Inc
  • STEMCELL Technologies Inc
  • Celprogen Inc
  • BrainStorm Cell Therapeutics Inc.
  • Stemedica Cell Technologies Inc
  • Merck KGaA (MilliporeSigma)
  • Smith+Nephew
  • Lonza AG
  • PromoCell GmbH
  • ScienCell Research Laboratories
  • American Type Culture Collection

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 24 May 2021

Packaged Salad Market Plying for Significant Growth During 2021-2028: Grand View Research Inc.

 Packaged Salad Market Growth & Trends

The global packaged salad market size is expected to reach USD 20.30 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.2% from 2021 to 2028. The growing trend of a healthy lifestyle is one of the key factors that will drive the market over the forecast period. Furthermore, the busy schedules of the millennials leave less time for cooking and various other kitchen chores, and thus people have been demanding ready-to-eat salads.

In recent years, it has been noted that consumers have been opting for vegetables and similar raw ingredients instead of fast foods and processed foods. The increasing focus on weight management owing to rising obesity levels is propelling the demand for packaged salads among consumers around the world. The low caloric content of packaged salads makes them ideal for weight management.

The vegetarian product segment dominated the market with a 67.4% share in 2020. The demand for vegetarian products is significantly growing owing to the rising vegan population around the world. The growing awareness regarding the high carbon footprint of the meat industry, along with animal health and animal cruelty, is compelling an increasing number of consumers to opt for vegetarian products instead.

Organically processed products are expected to expand at the highest CAGR of 8.6% over the forecast period. Organically processed products are generally perceived to contain more nutrients and antioxidants than conventional counterparts. Health-conscious consumers who focus on reducing their exposure to artificial chemicals and antibiotic-resistant bacteria usually prefer organically processed products to conventionally processed alternatives.

Mergers & acquisitions, new product launches, and production capacity expansion are some of the key strategic initiatives taken up by the companies to gain a competitive advantage over other players. In May 2020, Dole Food Company Inc. debuted its DOLE FreshTakes Ready-To-Eat Salad Bowls in the Western U.S. after its successful debut in the Eastern U.S. in 2019.

Request a free sample copy or view report summary: Packaged Salad Market Report

Packaged Salad Market Report Highlights

  • The packaged kits type segment is anticipated to register the fastest CAGR of 8.4% from 2021 to 2028. The increasingly hectic lifestyles and rising number of single-person households have been driving the segment
  • The online distribution channel is expected to register the fastest CAGR of 9.0% from 2021 to 2028 due to the increasing presence of online retailers
  • North America led the market by accounting for more than 41.0% in 2020. The busy lifestyle of the consumers has been propelling the demand for these conveniently packaged salads in the region
  • The vegetarian product segment held the largest share of 67.4% in 2020 owning to the growing number of health-conscious consumers across the globe

Access Press Release@ https://www.grandviewresearch.com/press-release/global-packaged-salad-market

Packaged Salad Market Segmentation

Grand View Research has segmented the global packaged salad market on the basis of product, processing, type, distribution channel, and region:

Packaged Salad Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Vegetarian
  • Non-vegetarian

Packaged Salad Processing Outlook (Revenue, USD Million, 2016 - 2028)

  • Organic
  • Conventional

Packaged Salad Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Packaged Greens
  • Packaged Kits

Packaged Salad Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Offline
  • Online

Packaged Salad Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
  • Asia Pacific
    • China
    • India
    • Australia
  • Central & South America
    • Brazil
  • Middle East & Africa

List of Key Players of Packaged Salad Market

  • BrightFarms, Inc.
  • Dole Food Company, Inc.
  • Earthbound Farm
  • Eat Smart (Curation Foods)
  • Fresh Express, Incorporated
  • Misionero
  • Gotham Greens Holdings, LLC
  • Mann Packing Co., Inc.
  • Bonduelle
  • Organicgirl, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...